As part of the panel session "Russian-Chinese Cooperation," a section was held on "Business with China in Pharmaceuticals 2025–2030: From Establishing Joint Ventures to Formula Protection and Cross-Border Payments," which was devoted to practical models of interaction between Russian and Chinese pharmaceutical companies. Participants discussed new partnership formats, legal risks, logistics, and financial mechanisms of cooperation.
The session moderator, Anastasia Valova, Managing Partner at Sinorus, noted that China has transformed from a manufacturing base into a full-fledged technological partner with its own R&D competencies. According to her, successful interaction requires a strategic approach, maintaining control over technologies, and a pre‑established financial architecture for projects. Key cooperation formats identified included contract manufacturing, joint development, technology localization, and the establishment of joint ventures.
Logistical aspects were presented by Sergey Belov, Deputy Director of ImpexTransService LLC, who emphasized the need for careful preparation of shipping documentation, supply insurance, and consideration of sanctions restrictions when choosing routes. Special attention was paid to the specifics of transportation within China and the requirements for packaging and labeling of equipment.
Vladislav Shiyanov, Head of Pharmaceutical, Medicine, and Biotechnology Practice at Nextons, focused on China's strategic role as a supplier of pharmaceutical substances and technological solutions. Among the sustainable cooperation models, he highlighted direct contracts with API manufacturers, technology transfer, and phased localization of production, with mandatory protection of intellectual property and quality control.
Vladimir Chernobrovtsev, Executive Director of Itorch LLC, presented technological solutions from Etorch Pharmtech Co., Ltd. for the production of liquid dosage forms and comprehensive equipping of pharmaceutical enterprises, which make it possible to reduce production risks and increase the efficiency of localization projects.
Based on the discussion outcomes, participants agreed that during the period 2025–2030, Russian-Chinese cooperation will develop toward long-term strategic alliances based on technological partnership, transparent contractual mechanisms, and sustainable logistics solutions.
The session moderator, Anastasia Valova, Managing Partner at Sinorus, noted that China has transformed from a manufacturing base into a full-fledged technological partner with its own R&D competencies. According to her, successful interaction requires a strategic approach, maintaining control over technologies, and a pre‑established financial architecture for projects. Key cooperation formats identified included contract manufacturing, joint development, technology localization, and the establishment of joint ventures.
Logistical aspects were presented by Sergey Belov, Deputy Director of ImpexTransService LLC, who emphasized the need for careful preparation of shipping documentation, supply insurance, and consideration of sanctions restrictions when choosing routes. Special attention was paid to the specifics of transportation within China and the requirements for packaging and labeling of equipment.
Vladislav Shiyanov, Head of Pharmaceutical, Medicine, and Biotechnology Practice at Nextons, focused on China's strategic role as a supplier of pharmaceutical substances and technological solutions. Among the sustainable cooperation models, he highlighted direct contracts with API manufacturers, technology transfer, and phased localization of production, with mandatory protection of intellectual property and quality control.
Vladimir Chernobrovtsev, Executive Director of Itorch LLC, presented technological solutions from Etorch Pharmtech Co., Ltd. for the production of liquid dosage forms and comprehensive equipping of pharmaceutical enterprises, which make it possible to reduce production risks and increase the efficiency of localization projects.
Based on the discussion outcomes, participants agreed that during the period 2025–2030, Russian-Chinese cooperation will develop toward long-term strategic alliances based on technological partnership, transparent contractual mechanisms, and sustainable logistics solutions.